120 related articles for article (PubMed ID: 23672049)
21. The effects of a novel anti-arrhythmic drug, acehytisine hydrochloride, on the human ether-a-go-go related gene K channel and its trafficking.
Huang X; Yang Y; Zhu J; Dai Y; Pu J
Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):145-54. PubMed ID: 19143746
[TBL] [Abstract][Full Text] [Related]
22. Allitridin reduces I Kr current by disrupting the trafficking of human ether-à-go-go-related gene channels.
Li G; Cheng G; Wu J; Ma S; Zhang A; Han W; Sun C
Cardiology; 2014; 128(1):1-8. PubMed ID: 24504171
[TBL] [Abstract][Full Text] [Related]
23. Structure-activity relationships of pentamidine-affected ion channel trafficking and dofetilide mediated rescue.
Varkevisser R; Houtman MJ; Linder T; de Git KC; Beekman HD; Tidwell RR; Ijzerman AP; Stary-Weinzinger A; Vos MA; van der Heyden MA
Br J Pharmacol; 2013 Jul; 169(6):1322-34. PubMed ID: 23586323
[TBL] [Abstract][Full Text] [Related]
24. L539 fs/47, a truncated mutation of human ether-a-go-go-related gene (hERG), decreases hERG ion channel currents in HEK 293 cells.
Zhang A; Sun C; Zhang L; Lv Y; Xue X; Li G; Cui C; Yan GX
Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):28-36. PubMed ID: 23134353
[TBL] [Abstract][Full Text] [Related]
25. Extracellular K+ is a prerequisite for the function and plasma membrane stability of HERG channels.
Massaeli H; Guo J; Xu J; Zhang S
Circ Res; 2010 Apr; 106(6):1072-82. PubMed ID: 20133899
[TBL] [Abstract][Full Text] [Related]
26. The antiandrogenic effect of neferine, liensinine, and isoliensinine by inhibiting 5-α-reductase and androgen receptor expression via PI3K/AKT signaling pathway in prostate cancer.
Liu CM; Wu Z; Pan B; An L; Zhu C; Zhou J; Jiang Y
Pharmazie; 2021 May; 76(5):225-231. PubMed ID: 33964997
[TBL] [Abstract][Full Text] [Related]
27. The enhancement of cardiotoxicity that results from inhibiton of CYP 3A4 activity and hERG channel by berberine in combination with statins.
Feng P; Zhao L; Guo F; Zhang B; Fang L; Zhan G; Xu X; Fang Q; Liang Z; Li B
Chem Biol Interact; 2018 Sep; 293():115-123. PubMed ID: 30086269
[TBL] [Abstract][Full Text] [Related]
28. Identification of IKr and its trafficking disruption induced by probucol in cultured neonatal rat cardiomyocytes.
Guo J; Massaeli H; Li W; Xu J; Luo T; Shaw J; Kirshenbaum LA; Zhang S
J Pharmacol Exp Ther; 2007 Jun; 321(3):911-20. PubMed ID: 17377062
[TBL] [Abstract][Full Text] [Related]
29. Clenbuterol Attenuates hERG Channel by Promoting the Mature Channel Degradation.
Luo L; Hu P; Miao C; Ma A; Wang T
Int J Toxicol; 2017; 36(4):314-324. PubMed ID: 28535735
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological inhibition of the hERG potassium channel is modulated by extracellular but not intracellular acidosis.
DU CY; El Harchi A; Zhang YH; Orchard CH; Hancox JC
J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1163-70. PubMed ID: 21489024
[TBL] [Abstract][Full Text] [Related]
31. The EGFP/hERG fusion protein alter the electrophysiological properties of hERG channels in HEK293 cells.
Huang N; Lian JF; Huo JH; Liu LY; Ni L; Yang X; Zhou JQ; Li ZF; Song TS; Huang C
Cell Biol Int; 2011 Mar; 35(3):193-9. PubMed ID: 21143190
[TBL] [Abstract][Full Text] [Related]
32. Effect of daurisoline on HERG channel electrophysiological function and protein expression.
Liu Q; Mao X; Zeng F; Jin S; Yang X
J Nat Prod; 2012 Sep; 75(9):1539-45. PubMed ID: 22974355
[TBL] [Abstract][Full Text] [Related]
33. [Effect of sophocarpine on HERG K+ channels].
Qi ZP; Shi SS; Zhao XL; Zhao WX; Bai YL; Lü YJ; Li BX; Yang BF
Yao Xue Xue Bao; 2008 Jan; 43(1):44-9. PubMed ID: 18357730
[TBL] [Abstract][Full Text] [Related]
34. HERG-F463L potassium channels linked to long QT syndrome reduce I(Kr) current by a trafficking-deficient mechanism.
Yang HT; Sun CF; Cui CC; Xue XL; Zhang AF; Li HB; Wang DQ; Shu J
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):822-7. PubMed ID: 19215240
[TBL] [Abstract][Full Text] [Related]
35. Protein kinase A-mediated phosphorylation of HERG potassium channels in a human cell line.
Wei Z; Thomas D; Karle CA; Kathöfer S; Schenkel J; Kreye VA; Ficker E; Wible BA; Kiehn J
Chin Med J (Engl); 2002 May; 115(5):668-76. PubMed ID: 12133532
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous determination of liensinine, isoliensinine and neferine in rat plasma by UPLC-MS/MS and application of the technique to pharmacokinetic studies.
Hu G; Xu RA; Dong YY; Wang YY; Yao WW; Chen ZC; Chen D; Bu T; Ge RS
J Ethnopharmacol; 2015 Apr; 163():94-8. PubMed ID: 25636663
[TBL] [Abstract][Full Text] [Related]
37. In vitro characterization of ABC transporters involved in the absorption and distribution of liensinine and its analogs.
Yu L; Shen Q; Zhou Q; Jiang H; Bi H; Huang M; Zhou H; Zeng S
J Ethnopharmacol; 2013 Nov; 150(2):485-91. PubMed ID: 24036064
[TBL] [Abstract][Full Text] [Related]
38. Hydroxypropyl beta-cyclodextrins: a misleading vehicle for the in vitro hERG current assay.
Mikhail A; Fischer C; Patel A; Long MA; Limberis JT; Martin RL; Cox BF; Gintant GA; Su Z
J Cardiovasc Pharmacol; 2007 May; 49(5):269-74. PubMed ID: 17513944
[TBL] [Abstract][Full Text] [Related]
39. The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines.
Kupershmidt S; Yang IC; Hayashi K; Wei J; Chanthaphaychith S; Petersen CI; Johns DC; George AL; Roden DM; Balser JR
FASEB J; 2003 Dec; 17(15):2263-5. PubMed ID: 14525949
[TBL] [Abstract][Full Text] [Related]
40. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
